Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Mesothelioma Cancer treatment details. Biologic therapy. Netherlands Cancer Institute, Amsterdam, Netherlands



Survival: 10.6 months
   
Toxicity Grade: 4
   
Treatments: Biologic therapy
   
Drugs:
Country: Netherlands
   
City/State/Province: Amsterdam
   
Hospital: Netherlands Cancer Institute
   
Journal: Link
   
Date: 5/2013

Description:
Patients:
This phase 3 study involved 111 malignant pleural mesothelioma patients who had previously received chemotherapy that contained pemetrexed. The median patient age was 64 years and 83% were male.

Treatment:
Patients were treated with the biologic therapy agent thalidomide.

Toxicities:
The most severe toxicities were of grade 4 and included neutropenia and fatigue.

Results:
The median overall survival was 10.6 months.

Support:
This study was partially supported by Eli Lilly.

Correspondence: Dr. Wieneke A Buikhuisen; email: w.buikhuisen@nki.nl

E-mail to a Friend Email Physician More Information